Search

everythinglearnresearchcommunity

for

Search:↓

The conference presented findings on how vitamin D levels, genetic factors, and lifestyle choices like smoking and yoga affect various health conditions and diseases.

The document concludes that management strategies for PCOS are important due to its common occurrence and associated health risks.

Treat hair loss with medicine, continue indefinitely.

Nutraceuticals that promote hair growth do not reduce tamoxifen's effectiveness in breast cancer treatment.

Hair loss greatly affects quality of life, and dermatologists are crucial for proper diagnosis and treatment.

Resistance training improved BMI and menstrual regularity more in women with PCOS than aerobic training.

Vitamin D is crucial for skin health and managing skin diseases.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Antimalarial agents are effective for LPP, and intralesional steroids are effective for FFA.

The document concludes that scalp conditions have various causes and can present in many different ways.

The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.

Women with PCOS often have irregular periods, a higher chance of infertility and miscarriages, and may improve fertility with lifestyle changes and treatment.

Finasteride may help postmenopausal women with hair loss but is not effective for all and should be used cautiously in premenopausal women.

Women's hair gets thinner and grayer as they age, with treatments available for hair loss and graying.

PCOS increases the risk of heart disease and type 2 diabetes in women.

In 2009, there were new medical devices, treatments for gynecological conditions, updated health guidelines, and legal developments in women's health.

Parthenolide promotes hair growth in mice and may influence pathways related to male pattern baldness.

Testosterone's role in women's sex drive is unclear and needs more research, as low levels don't always mean less sexual interest and high levels can cause side effects.

Early signs of PCOS in girls, like irregular periods and polycystic ovaries, suggest a need for early diagnosis and intervention to prevent further health issues.

Estradiol-rich plasma can increase hair density faster and more effectively in male pattern baldness treatment than regular plasma.

The study found that Frontal Fibrosing Alopecia in North-East India mainly affects middle-aged women and is often associated with lichen planus pigmentosus.

Increased scalp sweating in frontal fibrosing alopecia may be linked to local skin inflammation.

MicroRNAs could be key biomarkers and therapeutic targets for PCOS.

Polycystic Ovary Syndrome (PCOS) is not very common among Iranian women, but it's important to prevent it because of the risk of heart disease and infertility.

Women with PCOS are much more likely to experience depression.

Mesotherapy with bicalutamide has limited effectiveness for female hair loss.

No strong link between testosterone or DHEAS levels and acne or hair loss in females.

Too much prolactin can cause menstrual problems, infertility, and sexual issues in women.

Women with PCOS have more severe liver disease.

TNFα, IFNγ, and Substance P significantly affect prolactin levels in human skin, suggesting new treatments for skin and hair conditions.